Multimorbidity, Polypharmacy, and COVID-19 infection within the UK Biobank cohort (2020)

First Author: McQueenie R

Attributed to: Interrogating disease clusters, multimorbidity and adverse outcomes in chronic kidney disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2020.06.10.20127563

Publication URI: http://dx.doi.org/10.1101/2020.06.10.20127563

Type: Preprint